Back to News
Market Impact: 0.5

Why Rocket Lab Stock Skyrocketed Last Week

M&A & RestructuringCorporate Guidance & OutlookCompany FundamentalsCapital Returns (Dividends / Buybacks)Market Technicals & Flows

Rocket Lab agreed to acquire Iridium Communications for roughly $8B (50% cash/50% RKLB stock) in a deal expected to close in mid-2027, as RKLB shares jumped 24% last week. The transaction combines Iridium’s $411M trailing-12-month operating cash generation with Rocket Lab’s $161M cash burn, though Rocket Lab would likely fund part of the purchase with new debt and shareholder dilution. Despite the strategic benefits (spectrum, 66 satellites, and 2.55M subscribers), the article flags stretched valuation—RKLB at 82x sales—implying upside potential but elevated risk of overpaying.

Analysis

RKLB is using a high-multiple currency to buy a cash-generating asset, but the market is likely overestimating how quickly that translates into per-share value. The near-term winner is really the financing story: a mature, recurring revenue base can subsidize a development-heavy platform business, yet that same structure usually leaves the acquirer exposed to dilution, leverage, and a harder-to-defend valuation once the narrative cools. Competitively, this is a move into the same strategic battleground as ASTS, GSAT, VSAT, and EchoStar, where spectrum control and subscriber stickiness matter more than launch capability.

The key catalyst path is months to years, not days. In the next 1-3 months, momentum can keep RKLB bid as investors extrapolate “vertical integration”; over 6-18 months, the stock is vulnerable if debt costs rise, integration assumptions look optimistic, or launch execution wobbles while management is distracted. The main falsifiers are a meaningfully better financing package than expected, faster-than-expected cash conversion, or incremental contracts that prove the combined story is truly accretive rather than just larger.

Contrarian view: the consensus may be missing that this is more a multiple event than an earnings event. The market is paying today for a 2027 outcome, so any delay or disclosure on covenants, cap structure, or regulatory approvals could re-rate RKLB sharply lower. IRDM, by contrast, has more obvious downside support from the transaction structure and should be the cleaner event-driven asset if the spread offers enough carry.

More News